Insider Trading History of Smith Scott Andrew


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Smith Scott Andrew since year 2005. The trader's CIK number is 1614975. At the time of the last reporting, Smith Scott Andrew was the Director of Spring Bank Pharmaceuticals, Inc. . (stock ticker symbol SBPH). See this page for all insider trading activities at Spring Bank Pharmaceuticals, Inc. .

Note that in the past Smith Scott Andrew also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Smith Scott Andrew since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-28 SBPH Spring Bank Pharmaceuticals, Inc. Buy 12,000 4.09 49,080
2018-02-17 CELG Celgene Corp /de/ Option Ex 7,283 .00 0
2017-12-19 CELG Celgene Corp /de/ Option Ex 3,410 .00 0
2017-07-28 CELG Celgene Corp /de/ Option Ex 5,000 .00 0
2016-12-23 CELG Celgene Corp /de/ Option Ex 6,400 .00 0
2016-12-02 CELG Celgene Corp /de/ Option Ex 3,750 .00 0
2016-12-02 CELG Celgene Corp /de/ Option Ex 3,750 .00 0
2016-04-29 CELG Celgene Corp /de/ Option Ex 10,000 .00 0
2015-12-17 CELG Celgene Corp /de/ Option Ex 5,000 .00 0
2015-12-03 CELG Celgene Corp /de/ Option Ex 10,000 .00 0
2015-04-30 CELG Celgene Corp /de/ Option Ex 6,666 .00 0
2014-11-30 CELG Celgene Corp /de/ Option Ex 6,670 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Scott Andrew (Director of Spring Bank Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.